Nature子刊 | 单细胞转录组揭示横纹肌肉瘤免疫抑制和临床预后特征
近日,来自荷兰的 Thanasis Margaritis 和 Jarno Drost 团队发表于 Nature communications 题为 Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma 的文章, 通过比较融合基因阳性横纹肌肉瘤(FP RMS)和融合基因阴性横纹肌肉瘤(FN RMS)的转录组图谱,揭示了两种横纹肌肉瘤分子亚型之间和分子亚型内的细胞成分和分化状态的差异,这种差异与临床预后相关,也是潜在免疫治疗靶点。
首先,不同亚型横纹肌肉瘤样本中的肿瘤细胞分子特征显著不同,肿瘤细胞与正常细胞(主要指免疫细胞)的相互作用会抑制免疫细胞对肿瘤细胞响应,比如在融合基因阳性的RMS中,NECTIN3在肿瘤细胞上高表达,TIGIT受体在Tregs和CD8+T细胞上高表达,抑制CD8+T细胞对NECTIN3表达肿瘤细胞的杀伤作用。除此之外,对RMS中肿瘤微环境中免疫细胞比例和类型的分析还发现M2极化巨噬细胞的广泛存在,融合阳性RMS中的特异性T细胞的减少,部分可能是由NECTIN3和TIGIT之间的相互作用引起。
撰文
责编
制作
排版 | Sheila 校对 | uu
延伸阅读
*本文由深圳市拾玉儿童公益基金会“儿童肿瘤前沿”团队编译或约稿,文中图表均源引自文献原文。本文著作权归文章作者所有,欢迎个人转发分享,未经允许禁止转载,作者拥有所有法定权利,违者必究。如需转载,请留言或联系[email protected]。本文旨在分享儿童肿瘤科研前沿成果,不是治疗方案推荐。如需获得疾病治疗方案指导,请前往正规医院就诊。
▼滑动查看更多▼
原文摘要(Abstract)
Paediatric rhabdomyosarcoma (RMS) is a soft tissue malignancy of mesenchymal origin that is thought to arise as a consequence of derailed myogenic differentiation. Despite intensive treatment regimens, the prognosis for high-risk patients remains dismal. The cellular differentiation states underlying RMS and how these relate to patient outcomes remain largely elusive. Here, we use single-cell mRNA sequencing to generate a transcriptomic atlas of RMS. Analysis of the RMS tumour niche reveals evidence of an immunosuppressive microenvironment. We also identify a putative interaction between NECTIN3 and TIGIT, specific to the more aggressive fusion-positive (FP) RMS subtype, as a potential cause of tumour-induced T-cell dysfunction. In malignant RMS cells, we define transcriptional programs reflective of normal myogenic differentiation and show that these cellular differentiation states are predictive of patient outcomes in both FP RMS and the less aggressive fusion-negative subtype. Our study reveals the potential of therapies targeting the immune microenvironment of RMS and suggests that assessing tumour differentiation states may enable a more refined risk stratification.
DOI: 10.1038/s41467-023-38886-8